BIOMAT Database Logo BIOMAT Database Logo

Toxicologic and metabolic studies on 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon). 1959

L O RANDALL, and R E BAGDON, and R ENGELBERG

UI MeSH Term Description Entries
D006571 Heterocyclic Compounds Cyclic compounds that include atoms other than carbon in their ring structure. Heterocyclic Compound,Compound, Heterocyclic,Compounds, Heterocyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077145 Sulfanilamide A short-acting sulfonamide used as an anti-infective agent. It has lower anti-bacterial activity than SULFAMETHOXAZOLE. 4-aminobenzenesulfonamide,Azol Polvo,Sulfanilamide Barium Salt,Sulfanilamide Cadmium Salt,Sulfanilamide Hydrochloride,Sulfanilamide Lithium Salt,Sulfanilamide Magnesium Salt,Sulfanilamide Monohydrate,Sulfanilamide Silver Salt,Sulfanilamide Sodium,Sulfanilamide Sodium Salt,Sulfanilamide Strontium Salt,Sulfanilamide Zinc Salt,Sulphanilamide,4 aminobenzenesulfonamide
D013424 Sulfanilamides Compounds based on 4-aminobenzenesulfonamide. The '-anil-' part of the name refers to aniline. Sulphanilamides
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide

Related Publications

L O RANDALL, and R E BAGDON, and R ENGELBERG
Chemotherapeutic studies with 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon).
November 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
L O RANDALL, and R E BAGDON, and R ENGELBERG
The bacteriologicoclinical evaluation of 2,4-dimethoxy-6-sulfanilamido-1, 3-diazine (Madribon) in various urological disorders associated with urinary tract infection.
September 1959, Annals of the New York Academy of Sciences,
L O RANDALL, and R E BAGDON, and R ENGELBERG
[Results obtained in 20 ambulatory patients treated with 2, 4-dimethoxy-6-sulfanilamido-1,3-diazine].
June 1960, La Semana medica,
L O RANDALL, and R E BAGDON, and R ENGELBERG
A new long-acting antibacterial sulfonamide, 2,4-dimethoxy-6-sulfanilamido-1,3-diazine: a comparative study.
January 1958, Antibiotics annual,
L O RANDALL, and R E BAGDON, and R ENGELBERG
[Clinical trial of a new broad-spectrum and long-acting antibacterial compound (2,4-dimethoxy-6-sulfanilamido-1,3-diazine)].
October 1959, Medicina,
L O RANDALL, and R E BAGDON, and R ENGELBERG
Toxicologic studies on 3',4'-dichloropropionanilide.
December 1972, Toxicology and applied pharmacology,
L O RANDALL, and R E BAGDON, and R ENGELBERG
Studies on cardiotonic agents. III. Synthesis of 1-[1-(6,7-dimethoxy-4-quinazolinyl)-4-piperidinyl]-3-substituted 2-imidazolidinone and 2-imidazolidinethione derivatives.
September 1990, Chemical & pharmaceutical bulletin,
L O RANDALL, and R E BAGDON, and R ENGELBERG
[Clinical study of 1:10-bis-1-(3:4-dimethoxybenzyl) 1:2:3:4-tetrahydro-6:7-dimethoxy-2-methylisoquinoline methylsulfate, a synthetic muscle relaxant].
January 1954, Acta anaesthesiologica,
L O RANDALL, and R E BAGDON, and R ENGELBERG
[On pharmacokinetics of rectal application, demonstrated on example of 4-sulfanilamido-5,6-dimethoxy-pyrimidine. 2. Experimental part].
December 1965, Arzneimittel-Forschung,
L O RANDALL, and R E BAGDON, and R ENGELBERG
[Curative action of 2-isopropyl-5-sulfanilamido-1, 3, 4-thiadiazole on human diabetes mellitus].
November 1955, Comptes rendus hebdomadaires des seances de l'Academie des sciences,
Copied contents to your clipboard!